|
... Healthcare (+++) +++-++++ Link Medicine Completes $40 million Series C Financing to Accelerate Development of First Disease-Modifying Treatments for Neurodegenerative Disorders Co-led by Clarus Ventures and SV Life Sciences,the Financing will ...
|
|
... Canada rings true as my family and I found out last February. That is when my mother was diagnosed with this dreaded disease. Prior to that date, I did not know what this acronym stood for, nevermind how it affected peoples lives. ALS was first ...
|
|
... and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease. Cleviprex Cleviprex is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment ...
|
|
... with MS were almost twice as likely to have received the vaccine called Engerix B three or more years before the disease's onset. Further studies will need to be done to determine whether the vaccine is a direct cause of the development of MS. The ...
|
|
... capital firm SV Life Sciences has offices in Boston, London and San Francisco. The capital will be used to bring its disease treatments from the preclinical stage into human trials. Cambridge-based Link Medicine's drug platform is based on research ...
|
|
... said. "Changing our habits to reduce our risk not only of cancer but also of other chronic diseases, such as heart disease and diabetes, could reduce our health costs that are eating us up and provide better lives for a lot of people," she said. "I ...
|
|
... more than 10,000 hours. She currently serves as a director of the Central Oklahoma Integrated Network System, Huntington's Disease Association, Traveler's Aid, Prevent Blindness Oklahoma, and Oklahoma Shakespeare in the Park. She also serves as ...
|
|
... there are few acceptable treatment options. NTI also has early-stage development programs for Alzheimer's and Huntington's diseases and rights to receive payments on an approved drug for Alzheimer's disease and an investigational drug in Phase 3 ...
|
|
... * Trey Gray, drummer for country duo Brooks and Dunn, is also holding a tournament to raise awareness about Huntington's disease. The Trey Gray Tee Off for a Cure is intended to raise support for the establishment of a Huntington's Disease Society ...
|
|
... diabetes patients has another problem. The ad promises cures for Alzheimer's even though leading scientists say the disease likely won't benefit. "Stem cell research could unlock cures for diabetes, cancer and Alzheimer's, too. But John McCain has ...
|
|
... antagonist at a non-peripheral, CNS receptor site 5-HT6, intended for the symptomatic treatment of Alzheimer's disease and other disorders of memory and cognition like Attention deficient hyperactivity, Parkinson, Schizophrenia. SUVN-502 is the lead ...
|
|
Duke University Medical Center scientists say they have found compounds that prevented brain injury and greatly improved survival in fruit flies with a Huntington's-like disease.
|
|
... the latest developments in hematology as well as therapies for diseases such as fibromyalgia, osteoporosis, huntington's disease, and cystic fibrosis. The sessions will focus on upcoming regulatory approvals, clinical data reporting, FDA Advisory ...
|